Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone

Eva Zold, Arpad Nagy, Katalin Devenyi, M. Zeher, Z. Barta

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Crohn's disease (CD) is a chronic relapsing and remitting autoinflammatory disorder of the gastrointestinal tract that has many intestinal and extraintestinal complications. The purpose of treatment is long-term remission, reduction of complications, and improvement of patients' quality of life. In many cases, this can be quite challenging and it is necessary to have a well thought out management strategy. We present the case of a 38-year-old woman with fistulizing CD that manifested as diffuse abdominal pain and bloody diarrhea accompanied by arthralgia. In addition, there were ulcerative lesions surrounded by cutaneous inflammation and erythema on her extremities, indicative of pyoderma gangrenosum. The patient was treated with high doses of parenteral methylprednisolone without any improvement and was started on adalimumab. A positive response to adalimumab therapy was observed: after 2 mo of therapy, the ulcerative skin lesion healed completely and the enterogastric fistula was closed after 5 mo adalimumab treatment. Adalimumab might be a suitable initial as well as maintenance therapy in patients with complicated CD.

Original languageEnglish
Pages (from-to)2293-2295
Number of pages3
JournalWorld Journal of Gastroenterology
Volume15
Issue number18
DOIs
Publication statusPublished - May 14 2009

Fingerprint

Pyoderma Gangrenosum
Crohn Disease
Therapeutics
Skin
Methylprednisolone
Arthralgia
Erythema
Abdominal Pain
Fistula
Gastrointestinal Tract
Diarrhea
Extremities
Quality of Life
Adalimumab
Inflammation

Keywords

  • Adalimumab
  • Crohn's disease
  • Pyoderma gangrenosum

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum : Two birds with one stone. / Zold, Eva; Nagy, Arpad; Devenyi, Katalin; Zeher, M.; Barta, Z.

In: World Journal of Gastroenterology, Vol. 15, No. 18, 14.05.2009, p. 2293-2295.

Research output: Contribution to journalArticle

@article{3163f0b165124dd7bb2bf9c531c80051,
title = "Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone",
abstract = "Crohn's disease (CD) is a chronic relapsing and remitting autoinflammatory disorder of the gastrointestinal tract that has many intestinal and extraintestinal complications. The purpose of treatment is long-term remission, reduction of complications, and improvement of patients' quality of life. In many cases, this can be quite challenging and it is necessary to have a well thought out management strategy. We present the case of a 38-year-old woman with fistulizing CD that manifested as diffuse abdominal pain and bloody diarrhea accompanied by arthralgia. In addition, there were ulcerative lesions surrounded by cutaneous inflammation and erythema on her extremities, indicative of pyoderma gangrenosum. The patient was treated with high doses of parenteral methylprednisolone without any improvement and was started on adalimumab. A positive response to adalimumab therapy was observed: after 2 mo of therapy, the ulcerative skin lesion healed completely and the enterogastric fistula was closed after 5 mo adalimumab treatment. Adalimumab might be a suitable initial as well as maintenance therapy in patients with complicated CD.",
keywords = "Adalimumab, Crohn's disease, Pyoderma gangrenosum",
author = "Eva Zold and Arpad Nagy and Katalin Devenyi and M. Zeher and Z. Barta",
year = "2009",
month = "5",
day = "14",
doi = "10.3748/wjg.15.2293",
language = "English",
volume = "15",
pages = "2293--2295",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "18",

}

TY - JOUR

T1 - Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum

T2 - Two birds with one stone

AU - Zold, Eva

AU - Nagy, Arpad

AU - Devenyi, Katalin

AU - Zeher, M.

AU - Barta, Z.

PY - 2009/5/14

Y1 - 2009/5/14

N2 - Crohn's disease (CD) is a chronic relapsing and remitting autoinflammatory disorder of the gastrointestinal tract that has many intestinal and extraintestinal complications. The purpose of treatment is long-term remission, reduction of complications, and improvement of patients' quality of life. In many cases, this can be quite challenging and it is necessary to have a well thought out management strategy. We present the case of a 38-year-old woman with fistulizing CD that manifested as diffuse abdominal pain and bloody diarrhea accompanied by arthralgia. In addition, there were ulcerative lesions surrounded by cutaneous inflammation and erythema on her extremities, indicative of pyoderma gangrenosum. The patient was treated with high doses of parenteral methylprednisolone without any improvement and was started on adalimumab. A positive response to adalimumab therapy was observed: after 2 mo of therapy, the ulcerative skin lesion healed completely and the enterogastric fistula was closed after 5 mo adalimumab treatment. Adalimumab might be a suitable initial as well as maintenance therapy in patients with complicated CD.

AB - Crohn's disease (CD) is a chronic relapsing and remitting autoinflammatory disorder of the gastrointestinal tract that has many intestinal and extraintestinal complications. The purpose of treatment is long-term remission, reduction of complications, and improvement of patients' quality of life. In many cases, this can be quite challenging and it is necessary to have a well thought out management strategy. We present the case of a 38-year-old woman with fistulizing CD that manifested as diffuse abdominal pain and bloody diarrhea accompanied by arthralgia. In addition, there were ulcerative lesions surrounded by cutaneous inflammation and erythema on her extremities, indicative of pyoderma gangrenosum. The patient was treated with high doses of parenteral methylprednisolone without any improvement and was started on adalimumab. A positive response to adalimumab therapy was observed: after 2 mo of therapy, the ulcerative skin lesion healed completely and the enterogastric fistula was closed after 5 mo adalimumab treatment. Adalimumab might be a suitable initial as well as maintenance therapy in patients with complicated CD.

KW - Adalimumab

KW - Crohn's disease

KW - Pyoderma gangrenosum

UR - http://www.scopus.com/inward/record.url?scp=67650116192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650116192&partnerID=8YFLogxK

U2 - 10.3748/wjg.15.2293

DO - 10.3748/wjg.15.2293

M3 - Article

C2 - 19437575

AN - SCOPUS:67650116192

VL - 15

SP - 2293

EP - 2295

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 18

ER -